ad

3 Pharmaceuticals Company, Flexible Hoses Maker and Power Equipment Maker Stocks With a Strong Future Roadmap: Lupin, Aeroflex Industries and CG Power and Industrial Solutions

Lupin, Aeroflex Industries and CG Power and Industrial Solutions: ROE of 12.4% to 23.8% and FY22 to FY26 revenue CAGR of 15.0% to 23.1%. Prices as of 16 Nov 2026.


17 Nov 2026 • 2:57 pm

3 Pharmaceuticals Company, Flexible Hoses Maker and Power Equipment Maker Stocks With a Strong Future Roadmap: Lupin, Aeroflex Industries and CG Power and Industrial Solutions

Quick Answer

The three generic drug, steel hose and power gear stocks to watch are Lupin, Aeroflex Industries and CG Power and Industrial Solutions. Their return on equity ranges from 12.4% to 23.8%, and their revenue compound annual growth from FY22 to FY26 ranges from 15.0% to 23.1%. Lupin has the highest return on equity at 23.8%, while CG Power and Industrial Solutions has the fastest revenue growth at 23.1% a year. Prices are based on the 16 November 2026 close, and this article is educational, not investment advice.

Generic drug, steel hose and power gear stocks give investors a way to track businesses that sit close to everyday demand in India. Lupin, Aeroflex Industries and CG Power and Industrial Solutions cover a pharmaceuticals company, a flexible hoses maker and a power equipment maker.

This list covers three generic drug, steel hose and power gear stocks with complete current figures: Lupin, Aeroflex Industries and CG Power and Industrial Solutions. Every figure comes from the latest reported financials and the 16 November 2026 market close. Companies without complete current figures were left out.

Click Here – Get Free Investment Predictions

What Are Generic Drug, Steel Hose and Power Gear Stocks?

Generic drug, steel hose and power gear stocks are listed companies that make generic and branded medicines for India, the United States and other markets, make stainless steel flexible hoses and assemblies for industry, and make transformers, motors and switchgear for power networks. Their earnings depend on medicine demand, industrial orders and power network spending.

Generic Drug, Steel Hose and Power Gear Stocks at a Glance

Company CMP (Rs) Market Cap (Rs Cr) P/E Industry P/E ROE (%) D/E
Lupin 1,976.7 89,343 16.1 36.0 23.8 0.29
Aeroflex Industries 494.1 6,368 94.9 20.4 12.4 0.02
CG Power and Industrial Solutions 818.7 134,561 108.5 43.9 15.1 0.01

On valuation, Lupin trades at a P/E below the industry P/E, while Aeroflex Industries and CG Power and Industrial Solutions trade above it, which reflects the growth the market already expects. Readers comparing generic drug, steel hose and power gear stocks should look at return on equity and debt together, since a high return earned with low debt is easier to sustain. With the Q2 FY27 results season close, investors in generic drug, steel hose and power gear stocks can use the coming numbers to test whether growth is holding.

Why Do Generic Drug, Steel Hose and Power Gear Stocks Have a Strong Roadmap in India?

Generic drug, steel hose and power gear stocks have a strong roadmap in India because steady demand for medicines, wider industrial use of flexible hoses and large spending on power networks keep widening the market for these companies.

  • Generic medicines. Patients need affordable treatment.
  • Flexible hoses. Industry needs safe fluid and gas lines.
  • Power equipment. Grids and factories need modern gear.

Why Lupin Features Among These Generic Drug, Steel Hose and Power Gear Stocks

Among the generic drug, steel hose and power gear stocks on this list, Lupin is a Mumbai-headquartered global pharmaceutical company with a presence in branded generics in India, complex generics and specialty products in the United States, and active ingredients, with strength in respiratory, cardiovascular, anti-diabetic and anti-infective therapies.

In the June 2026 quarter, revenue grew 32.5% year on year to Rs 8,407 crore, while net profit rose 16.0% to Rs 1,417 crore. Revenue rose from Rs 16,616 crore in FY22 to Rs 29,039 crore in FY26, a compound annual growth rate of 15.0%.

Net profit grew from Rs 1,936 crore in FY24 to Rs 5,355 crore in FY26, which works out to a compound annual growth rate of 66.3%. The company has a return on equity of 23.8%, a debt to equity ratio of 0.29 and a market capitalisation of Rs 89,343 crore. The stock trades at a P/E of 16.1, below the industry P/E of 36.0.

Roadmap: The company is building its pipeline of complex generics, inhalation products and biosimilars, and is widening its specialty portfolio in the United States. Its large Indian branded business and a presence in over 100 markets spread revenue across regions and therapies.

What to watch: Track key launches in the United States, especially in inhalation and complex injectables, and the growth of the India branded business.

Why Aeroflex Industries Features Among These Generic Drug, Steel Hose and Power Gear Stocks

Among the inhaler maker, braided hose and transformer shares on this list, Aeroflex Industries makes stainless steel flexible flow solutions such as flexible hoses, braided hoses and assemblies used in aerospace, pharma, steel and other industries.

The company has a return on equity of 12.4%, a debt to equity ratio of 0.02 and a market capitalisation of Rs 6,368 crore. The stock trades at a P/E of 94.9, above the industry P/E of 20.4.

Revenue rose from Rs 241 crore in FY22 to Rs 443 crore in FY26, a compound annual growth rate of 16.5%. Net profit grew from Rs 27.5 crore in FY22 to Rs 55.5 crore in FY26, which works out to a compound annual growth rate of 19.2%.

Roadmap: The company is expanding capacity and widening its range of high-specification flexible hoses for aerospace and industrial customers in India and overseas. Specialised products and long approvals support its customer relationships.

What to watch: Follow capacity expansion, export orders and demand from aerospace customers.

Why CG Power and Industrial Solutions Features Among These Generic Drug, Steel Hose and Power Gear Stocks

Among the three companies on this list, CG Power and Industrial Solutions makes transformers, motors, switchgear, drives and railway equipment for utilities, industry and railways, and has also entered semiconductor packaging.

Revenue rose from Rs 5,521 crore in FY22 to Rs 12,662 crore in FY26, a compound annual growth rate of 23.1%. Net profit grew from Rs 630 crore in FY22 to Rs 1,197 crore in FY26, which works out to a compound annual growth rate of 17.4%.

In the June 2026 quarter, revenue grew 15.8% year on year to Rs 3,364 crore, while net profit rose 15.5% to Rs 308 crore. The company has a return on equity of 15.1%, a debt to equity ratio of 0.01 and a market capitalisation of Rs 134,561 crore. The stock trades at a P/E of 108.5, above the industry P/E of 43.9.

Roadmap: The company is growing in power systems and industrial systems on the back of grid expansion and factory investment. It has built an outsourced semiconductor assembly and test plant, which opens a new technology line.

What to watch: Monitor the ramp-up of its semiconductor facility and order intake in power systems.

Lupin vs Aeroflex Industries vs CG Power and Industrial Solutions on Key Financials

The table below sets the three generic drug, steel hose and power gear stocks side by side on revenue, profit and margin, using reported figures.

Company FY22 Revenue (Rs Cr) FY26 Revenue (Rs Cr) Revenue CAGR (FY22-FY26) FY26 Net Profit (Rs Cr) FY26 Net Margin
Lupin 16,616 29,039 15.0% 5,355 18.4%
Aeroflex Industries 241 443 16.5% 55.5 12.5%
CG Power and Industrial Solutions 5,521 12,662 23.1% 1,197 9.5%

Lupin posts the highest return on equity in this group at 23.8%. Lupin has the largest FY26 revenue at Rs 29,039 crore, and CG Power and Industrial Solutions shows the fastest revenue growth with a 23.1% compound annual rate. A useful habit with generic drug, steel hose and power gear stocks is to check each new quarterly result against the capacity plans the company described earlier. Many investors spread money across several global generics, flexible hoses and electrical equipment stocks instead of one name, which keeps a single result from deciding the outcome.

Key Risks to Check Before Investing in Generic Drug, Steel Hose and Power Gear Stocks

Every theme carries risks that deserve a check before any decision. For these generic drug, steel hose and power gear stocks, the main points are: Long-term inhaler maker, braided hose and transformer shares holders usually track revenue growth, margins and cash flow side by side rather than relying on a single ratio.

  • Regulatory approvals. Plant inspections and approvals can affect supplies.
  • Order timing. Project awards can shift between periods.
  • Capex cycles. Customer spending on plants and projects can vary.

Treat this list as a starting point for research and not as a recommendation. Read the latest results presentation, check the management commentary on order books or capacity plans, and compare each company with its peers before you decide anything.

Use the Univest Stock Screener to filter generic drug, steel hose and power gear stocks by market capitalisation, P/E, ROE and growth, and build your own shortlist.

Final Thoughts on Generic Drug, Steel Hose and Power Gear Stocks

Generic drug, steel hose and power gear stocks work best when investors track growth, valuation and return on equity side by side. Lupin, Aeroflex Industries and CG Power and Industrial Solutions each have a clear plan to grow. Based on the 16 November 2026 close, Lupin trades at Rs 1,976.7, Aeroflex Industries at Rs 494.1 and CG Power and Industrial Solutions at Rs 818.7. Valuation matters as much as growth, so compare each company's P/E with its industry P/E before adding any of these generic drug, steel hose and power gear stocks to a watchlist.

Download the Univest iOS App or Univest Android App to track generic drug, steel hose and power gear stocks, set price alerts and get research-backed stock ideas.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

What are generic drug, steel hose and power gear stocks?

Ans. Generic drug, steel hose and power gear stocks are listed companies that make generic and branded medicines for India, the United States and other markets, make stainless steel flexible hoses and assemblies for industry, and make transformers, motors and switchgear for power networks. Their earnings depend on medicine demand, industrial orders and power network spending. This list looks at three of them, Lupin, Aeroflex Industries and CG Power and Industrial Solutions, using reported FY22 to FY26 financials and the 16 November 2026 closing prices.

Which generic drug, steel hose and power gear stocks are covered in this list?

Ans. This list covers Lupin, Aeroflex Industries and CG Power and Industrial Solutions. Based on the 16 November 2026 close, Lupin traded at Rs 1,976.7, Aeroflex Industries at Rs 494.1 and CG Power and Industrial Solutions at Rs 818.7. Their return on equity ranges from 12.4% to 23.8%, and their revenue compound annual growth from FY22 to FY26 ranges from 15.0% to 23.1%.

Why do generic drug, steel hose and power gear stocks have a strong future roadmap in India?

Ans. Generic drug, steel hose and power gear stocks have a strong roadmap in India because steady demand for medicines, wider industrial use of flexible hoses and large spending on power networks keep widening the market for these companies. The main drivers are as follows. Generic medicines. Patients need affordable treatment. Flexible hoses. Industry needs safe fluid and gas lines. Power equipment. Grids and factories need modern gear. Together these factors give the companies on this list a visible path for growth over the coming years.

How has Lupin performed financially?

Ans. Revenue rose from Rs 16,616 crore in FY22 to Rs 29,039 crore in FY26, a compound annual growth rate of 15.0%. Net profit grew from Rs 1,936 crore in FY24 to Rs 5,355 crore in FY26, which works out to a compound annual growth rate of 66.3%. In the June 2026 quarter, revenue grew 32.5% year on year to Rs 8,407 crore, while net profit rose 16.0% to Rs 1,417 crore. The company has a return on equity of 23.8%, a debt to equity ratio of 0.29 and a market capitalisation of Rs 89,343 crore. The stock trades at a P/E of 16.1, below the industry P/E of 36.0. Looking ahead, the company is building its pipeline of complex generics, inhalation products and biosimilars, and is widening its specialty portfolio in the United States. Its large Indian branded business and a presence in over 100 markets spread revenue across regions and therapies.

How has Aeroflex Industries performed financially?

Ans. Revenue rose from Rs 241 crore in FY22 to Rs 443 crore in FY26, a compound annual growth rate of 16.5%. Net profit grew from Rs 27.5 crore in FY22 to Rs 55.5 crore in FY26, which works out to a compound annual growth rate of 19.2%. The company has a return on equity of 12.4%, a debt to equity ratio of 0.02 and a market capitalisation of Rs 6,368 crore. The stock trades at a P/E of 94.9, above the industry P/E of 20.4. Looking ahead, the company is expanding capacity and widening its range of high-specification flexible hoses for aerospace and industrial customers in India and overseas. Specialised products and long approvals support its customer relationships.

How has CG Power and Industrial Solutions performed financially?

Ans. Revenue rose from Rs 5,521 crore in FY22 to Rs 12,662 crore in FY26, a compound annual growth rate of 23.1%. Net profit grew from Rs 630 crore in FY22 to Rs 1,197 crore in FY26, which works out to a compound annual growth rate of 17.4%. In the June 2026 quarter, revenue grew 15.8% year on year to Rs 3,364 crore, while net profit rose 15.5% to Rs 308 crore. The company has a return on equity of 15.1%, a debt to equity ratio of 0.01 and a market capitalisation of Rs 134,561 crore. The stock trades at a P/E of 108.5, above the industry P/E of 43.9. Looking ahead, the company is growing in power systems and industrial systems on the back of grid expansion and factory investment. It has built an outsourced semiconductor assembly and test plant, which opens a new technology line.

What risks should investors check before buying generic drug, steel hose and power gear stocks?

Ans. Investors should check a few risks before buying generic drug, steel hose and power gear stocks. Regulatory approvals. Plant inspections and approvals can affect supplies. Order timing. Project awards can shift between periods. Capex cycles. Customer spending on plants and projects can vary. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.

Is this list of generic drug, steel hose and power gear stocks investment advice?

Ans. No. This article is educational and uses publicly available data as of the 16 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.

Recent Articles

Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.

Reviews

user-review-1
user-review-2
user-review-3
user-review-4
user-review-5

RESEARCH ANALYST

Get SEBI Registered
advice on the stocks
trending today.

Get 3 FREE Trade Ideas

+91
for Startups Accelerator 2024

for Startups Accelerator 2024

Trusted by 1Cr Indians

Trusted by 1Cr Indians

Awarded No.1 by Economic Times

Awarded No.1 by Economic Times

GET THE APP

Join 1Cr users today.

SEBI Registered Analyst-backed Picks. Free Demat. One App

  • Free Demat account in under 5 minutes
  • Live market data — Nifty, Sensex, sector insights
  • SEBI Registered analyst-backed stock picks
Get it on Google PlayDownload on the App Store
Stocks:
All|a|b|c|d|e|f|g|h|i|j|k|l|m|n|o|p|q|r|s|t|u|v|w|x|y|z

Copyright 2026 Univest. All rights reserved.
Designed with ❤️ in India

arrow down